Focal therapy is a new revolutionary way for prostate cancer management, applied for the first time in Greece by IASO General. This new method is already applied in renowned centers in the USA and Europe, and delivers excellent results.

How the method is applied – Advantages

Focal therapy is a general term encompassing a variety of non invasive techniques used in the destruction of minor tumors inside the prostate gland. It is based on imaging techniques combining prostate MRI and transrectal ultrasound (fusion technique). In particular, images of the prostate and lesion (tumor) are obtained via MRI, which are then integrated into the ultrasound performed at that moment. A sensor provides 3-D guidance and thus we are directly oriented to the suspected site for biopsy specimen.

As soon as histology examination demonstrates the lesion to be cancerous, then, with extreme precision, the tumor is directly destroyed with a needle (bearing a laser fiber optic), percutaneously and without incisions, and prostate healthy cells and tissues are kept intact. The result is that common complications (incontinence, erectile dysfunction, etc) manifesting in prostate cancer surgical treatment do not occur. Usually, the procedure is performed under local anesthesia and the patient is discharged from the Clinic a few hours later.

The scope of focal therapy is to successfully destroy all cancerous sites, minimize side effects on the inside of the prostate gland, keep all the rest areas of the gland unaffected, and protect prostate normal tissue.

Indications

Focal therapy is offered as an alternative treatment option in men with minor (small-sized) localized prostate cancers.

For more information on the method, please call +30210 6502649, 210 6465359

For more press information:
IASO Group’s Department of Commercial Management: Ms Nancy Christopoulou, tel.: +30 210 6383917, 210 6502853, e-mail: [email protected],
Ms Chrysa Theoldorou, tel.: +30 210 6502660, e-mail: [email protected]